Nuclear Medicine Equipment Market Growth, Demand and Challenges of the Key Industry Players

1
Global Nuclear Medicine Equipment Market Research
and Forecast Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Nuclear Medicine Equipment Market
Research Report 2022-2027 According to the
latest report by IMARC Group, titled Nuclear
Medicine Equipment Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2022-2027, the global nuclear medicine
equipment market reached a value of US 2.7
Billion in 2021. Nuclear medicine is a branch
of radiology that is used for visualizing the
function and structure of a tissue, bone, system
or organ. It includes various therapies, such as
radioactive iodine, antibodies, phosphorus and
other materials therapy. Nuclear medicine
therapies are performed by introducing
radionuclides or radiopharmaceuticals into the
body. The behavior of the radionuclide is
measured through a gamma camera, generator,
nuclear reactor, and cyclotron. Nuclear medicine
is used for diagnosing various conditions, which
include brain tumors, and prostate, breast, lung,
and head and neck cancers. Besides this, it also
helps to detect organ enlargement, hematomas,
cysts, infections, arthritis, and fractures.
Request for a PDF sample of this report
https//www.imarcgroup.com/nuclear-medicine-equipm
ent-market/requestsample

4
Report Description and Highlights
Report Description
Global Nuclear Medicine Equipment Market
Trends The rising prevalence of heart-based
diseases, neurological disorders, and cancers has
led to an increase in the awareness regarding the
importance of early diagnosis, which is primarily
driving the market growth. The rising awareness
is further leading to the widespread
establishment of diagnostic centers, which is
fueling the demand for these systems. Other than
this, various technological advancements are
contributing to the growth of the market. For
instance, leading players have been developing
modern software that helps to improve the
acquisition, and image detail and sharpness of
gamma and positron emission tomography (PET)
cameras. Moreover, significant improvements in
the healthcare infrastructure, and a rapid shift
toward high-resolution imaging solutions are some
of the other factors that are creating a positive
outlook for the market. Looking forward, the
market is projected to reach US 4 Billion by
2027, expanding at a CAGR of 6.8 during the
forecast period (2022-2027). View Report TOC,
Figures and Tables https//www.imarcgroup.com/nuc
lear-medicine-equipment-market

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Product
• Single-Photon Emission Computed Tomography
• Standalone
• Hybrid
• Positron Emission Tomography
• Standalone
• Hybrid
• Planar Scintigraphy
•  
• Breakup by Application
• Neurology
• Oncology
• Cardiology
• Others

6
Report Description and Highlights
Report Description

•  
• Breakup by End User
• Hospitals
• Imaging Centers
• Academic and Research Institutes
• Others
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa 

7
Report Description and Highlights
Report Description

•  
• Competitive Landscape with Key Players
• Biodex Medical Systems Inc. (Mirion Technologies
  Inc.)
• Cardinal Health Inc.
• CMR Naviscan Corporation
• DDD-Diagnostic A/S
• Digirad Corporation
• General Electric Company
• Koninklijke Philips N.V.
• Mediso Ltd.
• Neusoft Corporation
• Siemens AG
• SurgicEye GmbH
• Toshiba Corporation.
•  

8
Key Questions Answered in the Report
Report Description

• How has the global nuclear medicine equipment
  market performed so far and how will it perform
  in the coming years?
• What has been the impact of COVID-19 on the
  global nuclear medicine equipment market?
• What are the key regional markets?
• What is the breakup of the market based on the
  product?
• What is the breakup of the market based on the
  application?
• What is the breakup of the market based on the
  end user?
• What are the various stages in the value chain of
  the industry?
• What are the key driving factors and challenges
  in the industry?
• What is the structure of the global nuclear
  medicine equipment market and who are the key
  players?
• What is the degree of competition in the
  industry?
•  

9
Table of Contents
Report Description
1   Preface2   Scope and Methodology    2.1  
 Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3   Executive Summary4  
Introduction    4.1    Overview    4.2    Key
Industry Trends5   Global Nuclear Medicine
Equipment Market    5.1    Market Overview   
5.2    Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

10
Table of Contents
Report Description
6   Market Breakup by Product    6.1  
 Single-Photon Emission Computed Tomography     
  6.1.1 Market Trends        6.1.2 Key
Segments           6.1.2.1 Standalone         
 6.1.2.2 Hybrid        6.1.3 Market Forecast   
6.2    Positron Emission Tomography        6.2.1
Market Trends        6.2.2 Key Segments       
   6.2.2.1 Standalone           6.2.2.2 Hybrid 
      6.2.3 Market Forecast    6.3    Planar
Scintigraphy        6.3.1 Market Trends       
6.3.2 Market Forecast 7   Market Breakup by
Application          Click here to visit the
complete table of content with list of figures
and tables https//www.imarcgroup.com/nuclear-med
icine-equipment-market/toc

11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
14

Contact Us